Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea

Purpose Triple-negative breast cancer (TNBC) accounts for 10–20% of all diagnosed BCs and it is enriched in BRCA1 mutation. Guidelines for Western countries suggest that BRCA 1 / 2 genetic testing should be done for patients with TNBC diagnosed less than 60 years, but there is lack of evidence suppo...

Ausführliche Beschreibung